![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United States | Publication | August 2023
Deal making got off to a slow start in 2023 with rising interest rates, persistent inflation and economic uncertainty continuing to weigh heavily on transactional activity. Private equity firms are sitting on approximately US$2 trillion of dry powder for private equity transactions. Despite recent challenges, these available cash reserves and highly liquid securities make deal makers hungry for mergers and acquisitions.
This article, first published in Law360, examines the factors that created a record amount of dry powder, caused by private equity firms raising hordes of liquidity from their investors, even though such firms have been unable to invest the money into viable companies. The article also discusses M&A opportunities for these firms, such as corporate valuations rising after the pandemic, distressed opportunities in cross-border transactions and all-cash deals.
Read the entire Law360 article, "Private Equity Dry Powder Will Likely Spur M&A Opportunities." Also, download Norton Rose Fulbright’s global M&A trends and risks report for more insights on this and other M&A topics.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023